Latest Schedule 13G passive stakes

RA Capital Management and its affiliates have reported beneficial ownership of 9.7% of Obsidian Therapeutics' common stock as of August 3, 2026.

Oaktree Capital Management LP has disclosed a beneficial ownership of 1,925,992 shares, representing 6.17% of the Class A Common Stock of Matthews International Corporation.

Novo Holdings A/S has reported acquiring a 5.1% stake in Obsidian Therapeutics, Inc., signaling a notable investment from a major life sciences focused firm.

Oaktree Capital Management LP has filed a Schedule 13G, revealing beneficial ownership of 4.99% of SharonAI Holdings Inc.'s Class A Ordinary Common Stock, including shares issuable upon conversion of convertible notes.

Jane Street Group, LLC and its affiliates have filed an amendment to their Schedule 13G, reporting beneficial ownership of 3.6% of Ascent Solar Technologies, Inc. common stock as of June 30, 2026.

Hill City Capital Master Fund LP and its affiliates have reported beneficial ownership of 12,891,300 shares, representing 8.4% of Array Technologies' common stock.

Oaktree Capital Management LP has disclosed beneficial ownership of 5.11% of Quantum Corporation's common stock as of June 30, 2026.

Jane Street Group, LLC, along with its affiliates, has amended its Schedule 13G filing to reflect changes in its beneficial ownership of Amprius Technologies, Inc. common stock.

RP Investment Advisors LP and its affiliated funds have disclosed a combined beneficial ownership of 3.2% in ProCap Acquisition Corp's Class A Ordinary Shares as of June 30, 2026.

Jane Street Group, LLC and its affiliates have filed a Schedule 13G, reporting beneficial ownership of 2.4% of Applied Optoelectronics, Inc. common stock as of June 30, 2026.

Hamilton Lane Advisors and the Regents of the University of Michigan have jointly reported beneficial ownership of 5.1% of Granite Ridge Resources, Inc. common stock.

Hudson Bay Capital Management LP and Sander Gerber have reported a beneficial ownership of 5.51% in Teamshares Inc. common stock, including shares issuable upon warrant exercise.

Prudential Financial, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of 4.5% of Acadian Asset Management Inc. common stock as of June 30, 2026.

Prudential Financial, Inc. has updated its Schedule 13G filing, reporting beneficial ownership of 4.5% of Acadian Asset Management Inc. common stock as of June 30, 2026.

Prudential Financial, Inc. has filed a Schedule 13G, reporting a 6.7% beneficial ownership in Palvella Therapeutics, Inc.

Prudential Financial, Inc. has filed a Schedule 13G, reporting a 6.7% beneficial ownership in Palvella Therapeutics, Inc.

Hudson Bay Capital Management LP and Sander Gerber have reported beneficial ownership of 6.40% of RRE Ventures Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Kibo Investments Pte. Ltd. has reported a beneficial ownership of 3,707,208 shares, representing 8.5% of the common stock in Genco Shipping & Trading Ltd.

Hudson Bay Capital Management LP and Sander Gerber have reported beneficial ownership of 6.10% of GSR V Acquisition Corp.'s Class A Ordinary Shares as of June 30, 2026.

Feis Equities LLC and Lawrence M. Feis have reported beneficial ownership of 553,126 Class A ordinary shares, representing 3.02% of the outstanding shares in JAB Acquisition Corp I.

Duff & Phelps Investment Management Co. has reported beneficial ownership of 9.3% of National Healthcare Properties, Inc.'s Class A Common Stock as of June 30, 2026.

Several First Trust entities have updated their beneficial ownership filings for Aimei Health Technology Co., Ltd., reporting significant holdings in the company's ordinary shares.

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. have filed a corrected Schedule 13G to accurately report their beneficial ownership of Kiora Pharmaceuticals, Inc. common stock.

Erik Otto has filed a Schedule 13G, reporting beneficial ownership of 90,000 American Depository Shares in Chemomab Therapeutics Ltd., representing 1.2% of the class.

Barry Martin Bordetsky has filed a Schedule 13G, reporting beneficial ownership of 164,589,333 shares, representing 11.4% of Vystar Corp's common stock.

MEITAV INVESTMENT HOUSE LTD has updated its beneficial ownership filing for Nayax Ltd., reporting a 5.00% stake in the company's ordinary shares.

JRJ Investor 1 LP and associated entities have filed an amendment to Schedule 13G, reporting zero shares beneficially owned in Marex Group plc as of June 30, 2026.

Marex Group plc filing confirms zero beneficial ownership of common stock by MASP Investor Limited Partnership, Forty Two Point Two Acquisition Limited, and BXR Group Holdings Limited as of June 30, 2026.

An amendment to Schedule 13G has been filed for Valaris Limited, detailing changes in beneficial ownership by Giovanni Agnelli B.V., Exor N.V., Lingotto Investment Management (UK) Limited, and Lingotto Investment Management LLP.

Lingotto Investment Management LLP, along with affiliated entities, has reported a 7.12% beneficial ownership of VEON Ltd. ADSs, with no immediate intent to influence control.